跳至主要内容
临床试验/TCTR20220222001
TCTR20220222001已完成1 期

Efficacy assessment of PURICAS DRAGON'S BLOOD SCAR GEL on acne spot reduction

ATURA REMADEE COMPANY LIMITED0 个研究点目标入组 33 人开始时间: 2022年2月22日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
33

研究概览

简要总结

The results showed that PURICA'S BLOOD SCAR GEL can reduce redness and darkness on the face after using the product for 14 days. No adverse event occurred in this study.

研究设计

研究类型
Interventional

入排标准

年龄范围
20 Years 至 50 Years(—)
性别
All

入选标准

  • 1. Healthy male or female aged between 20-50 years old
  • 2. Having at least 2 visible red or/and dark spots from acne on the face (diameter not less than 5 mm)
  • 3. Be able to read, write and communicate Thai language
  • 4. Having consent in the study after being informed objective, methodology, possible risk and result, and be able to follow the study protocol

排除标准

  • 1. Pregnancy or lactation
  • 2. Having allergic history to counter brand cosmetic products
  • 3. Having history of eczema or psoriasis within 6 months before enrollment in the study
  • 4. Having history of steroid, antibiotic, non-steroidal anti-inflammatory or antihistamine drug use within 3 days before enrollment in the study
  • 5. Using any products related to anti-acne in 14 days before participating in the study
  • 6. Regular smoking or drinking
  • 7. Having history of participating about anti-acne clinical research project running within 3 months before enrollment in the study

研究者

发起方
ATURA REMADEE COMPANY LIMITED

相似试验